...
首页> 外文期刊>Pharmacological reports: PR >Medium supplementation with zinc enables detection of imipramine-induced adaptation in glycine/NMDA receptors labeled with ((3)H)L-689,560.
【24h】

Medium supplementation with zinc enables detection of imipramine-induced adaptation in glycine/NMDA receptors labeled with ((3)H)L-689,560.

机译:含锌的培养基可以检测由((3)H)L-689,560标记的丙咪嗪/ NMDA受体中的丙咪嗪诱导的适应性。

获取原文
获取原文并翻译 | 示例
           

摘要

Antidepressant drugs after chronic administration induce adaptive changes in the NMDA receptor complex. Radioligand-receptorbinding studies using [(3)H]5,7-dichlorokynurenic acid demonstrated a "down-regulation" of the glycine site/NMDA receptor following chronic treatment with antidepressants and electroconvulsive shock. However, binding procedure using this radioligand is time consuming because it requires the use of centrifugation method in the separation process. The introduction of a new radioligand of glycine/NMDA receptor, [(3)H]L-689,560 enables the application of a rapid filtration method. In the present study we demonstrate that 2-week treatment with imipramine (15 mg/kg ip) did not evoke alterations in specific [(3)H]L-689,560 binding and in IC(50) value of glycine in displacing [(3)H]L-689,560 binding in the mouse or rat cortex. However, longer, a 4-week treatment with imipramine induced a significant 71% increase in IC(50) value in displacing [(3)H]L-689.560 binding in the mouse cortex. Moreover, the presence of zinc in the incubation media, dose-dependently enhances detection of imipramine-induced increase in IC(50) value of glycine in displacing [(3)H]L-689,560 binding in the rat cortex. The present data indicate that: (1) [(3)H]L-689,560 may be a suitable ligand for assessing adaptation of the glycine/NMDA sites and (2) the presence of zinc enhances detection of imipramine-induced reduction of glycine affinity for glycine/NMDA receptors labeled with [(3)H]L-689,560 which further indicates a significance of zinc in the mechanism of antidepressant treatment.
机译:长期给药后的抗抑郁药会诱导NMDA受体复合物的适应性变化。用[(3)H] 5,7-二氯尿嘧啶酸进行的放射性配体-受体结合研究表明,用抗抑郁药和电惊厥休克长期治疗后,甘氨酸位点/ NMDA受体“下调”。然而,使用这种放射性配体的结合过程是费时的,因为它需要在分离过程中使用离心方法。一种新的甘氨酸/ NMDA受体放射性配体[[(3)H] L-689,560]的引入使快速过滤方法的应用成为可能。在本研究中,我们证明用丙咪嗪(15 mg / kg ip)进行2周治疗不会引起特异性[(3)H] L-689,560结合和甘氨酸IC(50)取代[(3 H] L-689,560在小鼠或大鼠皮质中的结合。但是,更长的时间,用丙咪嗪治疗4周后,在置换小鼠皮质中的[(3)H] L-689.560结合中,IC(50)值引起71%的显着增加。此外,锌在温育培养基中的存在,剂量依赖性地增强了丙咪嗪诱导的甘氨酸IC(50)值增加的检测,从而取代了大鼠皮层中的[(3)H] L-689,560结合。本数据表明:(1)[(3)H] L-689,560可能是用于评估甘氨酸/ NMDA位点适应性的合适配体,并且(2)锌的存在增强了丙咪嗪诱导的甘氨酸亲和力降低的检测[(3)H] L-689,560标记的甘氨酸/ NMDA受体的作用,进一步表明锌在抗抑郁药治疗机制中的重要性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号